# Paediatric Ards Neuromuscular Blockade Study

> **NCT02902055** · PHASE4 · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 3 (actual)

## Conditions studied

- ARDS

## Interventions

- **DRUG:** Neuromuscular Blocking Agents
- **DRUG:** Isotonic saline

## Key facts

- **NCT ID:** NCT02902055
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** COVID-19, slow enrolment
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02902055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02902055, "Paediatric Ards Neuromuscular Blockade Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02902055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*